IRadimed Corp IRMD
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-07-16 |
| Shares Out. | 12,780,000 |
| Website | iradimed.com/ β |
| Phone | 14076778022 |
| Employees | 166 |
| Revenue | $22.0M |
| Gross Profit | $16.8M |
| Net Income | $5.8M |
| Free Cash Flow | $24.0M |
| Total Assets | $114.4M |
| Total Liabilities | $15.9M |
| Equity | $98.5M |
About IRadimed Corp
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
IRadimed Corp is a publicly traded company under the ticker symbol IRMD on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
8 analysts (2026-07-01)
